Aprea Therapeutics, Inc. (APRE)

Total Costs & Expenses

$13.22M

TTM · Period ending: · USD

APRE logo

APRE Total Costs & Expenses

Latest reported$13.22M
APRE TTM Total Costs & Expenses ($29.54M → $13.22M)
High-resolution chart · PNG

APRE total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Aprea Therapeutics, Inc. Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
13,223,073
12,696,777
13,514,409
14,303,178
15,637,427
16,540,041
15,822,236
16,079,378
15,470,059
14,962,930
16,055,194
15,017,818
15,375,694
109,939,856
113,392,228
118,569,279
123,799,496
35,331,547
37,446,353
43,841,076
46,644,970
51,128,303
52,811,212
50,567,568
45,551,618
37,009,118
29,544,298
22,463,910
18,176,279
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.